In conclusion, the present study suggests that CCR9 expression on CD4+ T cells is elevated in PB and SF of RA patients, and CCR9+CD4+ T cells are associated with disease activity and pro-inflammatory cytokines. This evidence concerns the gene CCR9 and rheumatoid arthritis.